Sorin Group (BIT:SRN) said today that data from a 1-year study of its Freedom Solo stentless pericardial aortic valve showed positive safety and efficacy results. The 251-patient study looked at individuals in North America with aortic valve disease who are implanted with the device, the Milan, Italy-based company said. Results showed a mean reduction in gradient […]
cyberonics
Sorin launches Kora 250 MRI-safe pacer in Europe
Sorin Group (BIT:SRN) said today it launched its next-generation Kora 250 MRI-safe pace maker in Europe. The Milan, Italy-based company said the device can automatically detect an MRI scanner’s magnetic field and ensure proper device operation during the scan. Sorin said it is the world’s smallest MRI-safe pacemaker to date. “At Sorin Group we have a […]
ConMed ripe for M&A | The week in medtech M&A
Analyst: ConMed ripe for M&A spree May 19, 2015 by Fink Densford ConMed, in the middle of an under-appreciated turnaround, could be poised to augment its growth via selective acquisitions, according to Leerink Partners analyst Richard Newitter. Newitter, who upgraded CNMD shares to “outperform” and boosted the price target to $64 from $60, wrote in […]
Sorin shareholders OK Cyberonics merger
Sorin Group (BIT:SRN) said shareholders met today and approved its upcoming merger with Cyberonics (NSDQ:CYBX). The deal, which is slated to bring together global leaders in neuromodulation and cardiac surgery with a combined equity value of $2.7 billion, is expected to close by the end of the 3rd quarter. Sorin stockowners will receive 0.0472 units of […]
BSX prices $1.85B debt offering | The week in medtech M&A
Sorin, Cyberonics introduce post-merger leaders
U.S. regulators OK $1.4B Sorin-Cyberonics tie-up
J&J deals Cordis for nearly $2B | The week in medtech M&A
UPDATE: Cyberonics to buy Italy’s Sorin for $1.4B
Mixed results for nerve stim in heart failure for Boston Scientific, Cyberonics
Cyberonics expands share buyback program
Cyberonics (NSDQ:CYBX) said it will expand its share repurchase program by an additional 1 million shares by the end of its 2015 fiscal year.